Bicycle Therapeutics Plc (BCYC)
3.38
-0.18
(-5.06%)
USD |
NASDAQ |
Oct 02, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics EPS Diluted (Quarterly) : -0.7224 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7224 |
| March 31, 2026 | -0.8714 |
| December 31, 2025 | -0.2901 |
| September 30, 2025 | -0.8474 |
| June 30, 2025 | -1.154 |
| March 31, 2025 | -0.8814 |
| December 31, 2024 | -0.744 |
| September 30, 2024 | -0.7439 |
| June 30, 2024 | -0.7666 |
| March 31, 2024 | -0.6238 |
| December 31, 2023 | -1.168 |
| September 30, 2023 | -1.254 |
| June 30, 2023 | -1.416 |
| March 31, 2023 | -1.314 |
| December 31, 2022 | -1.016 |
| September 30, 2022 | -0.9471 |
| June 30, 2022 | -0.897 |
| March 31, 2022 | -0.9257 |
| Date | Value |
|---|---|
| December 31, 2021 | -0.6105 |
| September 30, 2021 | -0.5835 |
| June 30, 2021 | -0.7433 |
| March 31, 2021 | -0.7351 |
| December 31, 2020 | -0.8349 |
| September 30, 2020 | -0.5312 |
| June 30, 2020 | -0.6718 |
| March 31, 2020 | -0.6296 |
| December 31, 2019 | -0.2491 |
| September 30, 2019 | -0.5264 |
| June 30, 2019 | -1.393 |
| March 31, 2019 | -0.4944 |
| December 31, 2018 | -0.4463 |
| September 30, 2018 | -0.4304 |
| June 30, 2018 | -0.2779 |
| March 31, 2018 | -0.1441 |
| December 31, 2017 | -0.3618 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -0.1472 |
| Akari Therapeutics Plc | -2.404 |
| Cellectis SA | -0.2165 |
| DBV Technologies SA | -0.5804 |
| Oxford Biomedica Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -50.42M |
| Revenue (Quarterly) | 0.6301M |
| Total Expenses (Quarterly) | 51.05M |
| Enterprise Value | -324.57M |
| Gross Profit Margin (Quarterly) | -69.64% |
| Profit Margin (Quarterly) | -8.00K% |
| Earnings Yield | -80.81% |
| Normalized Earnings Yield | -80.81 |